Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.84B | 1.80B | 1.74B | 1.67B | 1.68B | 1.58B |
| Cost of revenue | 845M | 852M | 850M | 802M | 782M | 723M |
| Research and development | 126M | 117M | 111M | 112M | 113M | 127M |
| Selling, general and administrative | 465M | 476M | 417M | 454M | 410M | 395M |
| Operating expenses | 1.44B | 1.45B | 1.38B | 1.37B | 1.31B | 1.25B |
| Operating income | 399M | 353M | 360M | 300M | 376M | 333M |
| Interest expense | 25M | 25M | 28M | 29M | 28M | 22M |
| Pre-tax income | 408M | 364M | 366M | 260M | 367M | 343M |
| Income tax | 69M | 59M | 30M | 45M | 49M | 61M |
| Net income | 339M | 305M | 336M | 215M | 318M | 282M |
| Earnings per share | 1.20 | 1.08 | 1.18 | 0.75 | 1.12 | 0.97 |
| Earnings per share, diluted | 1.20 | 1.07 | 1.18 | 0.75 | 1.11 | 0.97 |
| Weighted average shares | 282M | 283M | 284M | 285M | 285M | 290M |
| Weighted average shares, diluted | 283M | 284M | 285M | 285M | 287M | 291M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.81B | 1.76B | 1.79B | 1.54B | 1.49B | 1.47B | 1.33B | 1.78B |
| Receivables | 1.50B | 1.52B | 1.49B |
| Metric | 31 Jan 2026 | 31 Jan 2025 |
|---|---|---|
| Operating cash flow | 268M | 431M |
| Depreciation and amortisation | 67M | 72M |
| Share-based compensation | 41M | 40M |
| Capital expenditure | 93M | 97M |
| Investing cash flow | −93M | −94M |
| Share buybacks | 152M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 1.38B |
| 1.37B |
| 1.33B |
| 1.32B |
| 1.23B |
| Inventory | 1.09B | 1.06B | 1.03B | 1.01B | 991M | 997M | 972M | 978M |
| Current assets | 4.76B | 4.62B | 4.59B | 4.25B | 4.21B | 4.11B | 3.96B | 4.26B |
| Property, plant and equipment | 2.10B | 2.08B | 2.02B | 1.97B | 1.91B | 1.82B | 1.78B | 1.45B |
| Goodwill | 4.48B | 4.48B | 4.47B | 4.48B | 4.47B | 4.43B | 4.48B | 3.97B |
| Total assets | 13.07B | 12.81B | 12.73B | 12.23B | 12.16B | 11.91B | 11.85B | 11.00B |
| Current liabilities | 2.27B | 2.23B | 2.35B | 1.89B | 2.01B | 1.87B | 1.90B | 2.39B |
| Short-term debt | 304M | 304M | 304M | 59M | 146M | 16M | 45M | 795M |
| Long-term debt | 3.05B | 3.05B | 3.05B | 3.35B | 3.35B | 3.35B | 3.35B | 2.14B |
| Total liabilities | 5.94B | 5.91B | 5.99B | 5.86B | 6.02B | 5.89B | 5.95B | 5.09B |
| Equity | 7.12B | 6.91B | 6.74B | 6.37B | 6.14B | 6.03B | 5.90B | 5.90B |
| Shares outstanding | 282M | 283M | 283M | 284M | 284M | 285M | 285M | 288M |
| Shares issued | 282M | 283M | 283M | 284M | 284M | 285M | 285M | 288M |
| 90M |
| Financing cash flow | −222M | −180M |